Milford, CT, April 12, 2016 --(PR.com
)-- In a landmark decision, the medical establishment and the health insurance industry have decided to make doctors’ performance a priority.
This resolution will deeply impact how physicians who treat cancer patients are assessed and will inevitably have a positive effect on the quality of care in the United States. This shift in philosophy and outlook will also give patients more meaningful information on which to base their decisions when evaluating the quality of care offered by medical providers.
According to a study by the Institute of Medicine, “America's health care system has become far too complex and costly to continue business as usual. Pervasive inefficiencies, an inability to manage a rapidly deepening clinical knowledge base, and a reward system poorly focused on key patient needs, all hinder improvements in the safety and quality of care and threaten the nation's economic stability and global competitiveness. Achieving higher quality care at lower cost will require fundamental commitments to the incentives, culture, and leadership that foster continuous 'learning,' as the lessons from research and each care experience are systematically captured, assessed, and translated into reliable care.”
This call to action will directly affect how health officials and insurers strive to optimize care for patients in terms of lowering re-admittance rates, reducing overall costs and increasing accountability. As it stands, most insurers are required to cover the costs of repeat care, which would change if stricter standards are enacted.
Companies like Kubtec®, which focus on significantly improving quality of care and reducing re-admittance rates are leading the way with innovative technology which aims to limit re-excisions specifically in women with breast cancer. These measures are not only improving the quality of care for patients undergoing breast cancer surgery, but also enhancing physician performance by improving outcomes and elevating the standard of care.
Kubtec, a registered trademark of KUB Technologies, Inc., develops and manufactures digital X-ray systems for clinical and non-clinical applications, including low-dose neonatal imaging, specimen radiography, scientific research, forensic analysis, non-destructive testing, irradiation and more. Kubtec is ISO 9001 and ISO 13485 certified and complies with U.S., Canadian, and European requirements for radiation safety. Systems and manufacturer-trained support is available worldwide.